Chaim Gilon, Ph.D.
Affiliations: | Chemistry | Hebrew University, Jerusalem, Jerusalem, Israel |
Area:
Organic chemistry, Peptide chemistryGoogle:
"Chaim Gilon"Mean distance: 39813
Children
Sign in to add traineeGerardo Byk | grad student | 1986-1991 | Hebrew University chemistry |
Gal Bitan | grad student | 1990-1996 | Hebrew University (Neurotree) |
Assaf Friedler | grad student | 1994-2000 | Hebrew University |
Yftah Tal-Gan | grad student | 2011 | Hebrew University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Glavaš M, Gitlin-Domagalska A, Ptaszyńska N, et al. (2023) Synthesis of Novel Arginine Building Blocks with Increased Lipophilicity Compatible with Solid-Phase Peptide Synthesis. Molecules (Basel, Switzerland). 28 |
Talhami A, Swed A, Hess S, et al. (2020) Cyclizing Painkillers: Development of Backbone-Cyclic TAPS Analogs. Frontiers in Chemistry. 8: 532577 |
Gilon C, Gitlin-Domagalska A, Lahiani A, et al. (2020) Novel humanin analogs confer neuroprotection and myoprotection to neuronal and myoblast cell cultures exposed to ischemia-like and doxorubicin-induced cell death insults. Peptides. 170399 |
Mizrahi N, Gilon C, Atre I, et al. (2019) Deciphering Direct and Indirect Effects of Neurokinin B and GnRH in the Brain-Pituitary Axis of Tilapia. Frontiers in Endocrinology. 10: 469 |
Dishon S, Schumacher-Klinger A, Gilon C, et al. (2019) Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4-4), a Cyclic Peptide Inhibitor of MyD88. Molecular Pharmaceutics |
Naoum JN, Alshanski I, Gitlin-Domagalska A, et al. (2019) Diffusion-Enhanced Amide Bond Formation on a Solid Support Organic Process Research & Development. 23: 2733-2739 |
Räder AFB, Weinmüller M, Reichart F, et al. (2018) Orally active peptides - is there a magic bullet? Angewandte Chemie (International Ed. in English) |
Schumacher-Klinger A, Fanous J, Merzbach S, et al. (2018) Enhancing oral bioavailability of cyclic RGD hexa-peptides by the Lipophilic Prodrug Charge Masking approach: Redirection of peptide intestinal permeability from paracellular to transcellular pathway. Molecular Pharmaceutics |
Dishon S, Schumacher A, Fanous J, et al. (2018) Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88. Scientific Reports. 8: 9476 |
Rubin SJS, Tal-Gan Y, Gilon C, et al. (2018) Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads using Backbone Cyclization and Cycloscan - How to Do It Yourself. Current Topics in Medicinal Chemistry |